CXCL9 and psoriasis: Notably, LCs in psoriasis patients exhibit upregulation of C-X-C motif chemokine ligand 9 (CXCL9), which mediate the targeted recruitment of T lymphocytes to inflammatory foci, thereby amplifying the psoriatic immune cascade [116].